Oppenheimer & Co’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-84,525
| Closed | -$589K | – | 1517 |
|
|
2024
Q2 | $589K | Buy |
+84,525
| New | +$640K | 0.01% | 953 |
|
|
2021
Q4 | – | Sell |
-7,428
| Closed | -$207K | – | 1493 |
|
|
2021
Q3 | $207K | Sell |
7,428
-499
| -6% | -$14.2K | ﹤0.01% | 1387 |
|
|
2021
Q2 | $232K | Buy |
7,927
+1,100
| +16% | +$33.3K | ﹤0.01% | 1370 |
|
|
2021
Q1 | $217K | Sell |
6,827
-3,000
| -31% | -$88K | ﹤0.01% | 1317 |
|
|
2020
Q4 | $205K | Sell |
9,827
-200
| -2% | -$3.73K | ﹤0.01% | 1240 |
|
|
2020
Q3 | $156K | Sell |
10,027
-9,400
| -48% | -$162K | ﹤0.01% | 1193 |
|
|
2020
Q2 | $355K | Buy |
19,427
+69
| +0.4% | +$1.22K | 0.01% | 914 |
|
|
2020
Q1 | $300K | Buy |
19,358
+7,363
| +61% | +$178K | 0.01% | 899 |
|
|
2019
Q4 | $359K | Buy |
+11,995
| New | +$312K | 0.01% | 961 |
|
|
2018
Q4 | – | Sell |
-14,734
| Closed | -$378K | – | 1251 |
|
|
2018
Q3 | $378K | Sell |
14,734
-1,000
| -6% | -$22.9K | 0.01% | 972 |
|
|
2018
Q2 | $366K | Sell |
15,734
-4,216
| -21% | -$87.2K | 0.01% | 986 |
|
|
2018
Q1 | $318K | Sell |
19,950
-8,775
| -31% | -$163K | 0.01% | 1027 |
|
|
2017
Q4 | $597K | Sell |
28,725
-200
| -0.7% | -$3.17K | 0.02% | 799 |
|
|
2017
Q3 | $415K | Buy |
28,925
+1,198
| +4% | +$18.1K | 0.01% | 911 |
|
|
2017
Q2 | $479K | Sell |
27,727
-6,680
| -19% | -$80.1K | 0.01% | 849 |
|
|
2017
Q1 | $379K | Buy |
34,407
+10,647
| +45% | +$146K | 0.01% | 903 |
|
|
2016
Q4 | $344K | Sell |
23,760
-6,235
| -21% | -$114K | 0.01% | 944 |
|
|
2016
Q3 | $737K | Buy |
29,995
+10,344
| +53% | +$268K | 0.02% | 662 |
|
|
2016
Q2 | $396K | Buy |
19,651
+9,944
| +102% | +$282K | 0.01% | 870 |
|
|
2016
Q1 | $255K | Sell |
9,707
-748
| -7% | -$55.3K | 0.01% | 1000 |
|
|
2015
Q4 | $1.06M | Buy |
10,455
+3,541
| +51% | +$398K | 0.03% | 534 |
|
|
2015
Q3 | $1.23M | Sell |
6,914
-23,031
| -77% | -$5.37M | 0.04% | 506 |
|
|
2015
Q2 | $6.65M | Buy |
29,945
+3,444
| +13% | +$764K | 0.19% | 125 |
|
|
2015
Q1 | $5.26M | Buy |
26,501
+23,141
| +689% | +$4.11M | 0.14% | 168 |
|
|
2014
Q4 | $481K | Sell |
3,360
-50
| -1% | -$6.72K | 0.01% | 835 |
|
|
2014
Q3 | $447K | Sell |
3,410
-84
| -2% | -$10K | 0.01% | 891 |
|
|
2014
Q2 | $441K | Sell |
3,494
-4,474
| -56% | -$571K | 0.01% | 899 |
|
|
2014
Q1 | $1.05M | Buy |
7,968
+3,776
| +90% | +$516K | 0.03% | 590 |
|
|
2013
Q4 | $492K | Buy |
4,192
+1,431
| +52% | +$157K | 0.02% | 814 |
|
|
2013
Q3 | $288K | Buy |
+2,761
| New | +$269K | 0.01% | 988 |
|
Other funds holding BHC
IC
GAM
PC
IG
MMA
Oppenheimer & Co's BHC Position: Q3 2024 in Review
Oppenheimer & Co sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 84,525 shares — an estimated $589K sold.
Oppenheimer & Co first reported a position in BHC in Q3 2013 and held it in 30 quarters. The position peaked at $6.65M in Q2 2015. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.
- Oppenheimer & Co reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
- Oppenheimer & Co sold 84,525 Bausch Health shares in Q3 2024, an estimated $589K.
- Oppenheimer & Co first reported a position in Bausch Health in Q3 2013 and held it in 30 quarters.
- Oppenheimer & Co's Bausch Health position peaked at $6.65M in Q2 2015.
- 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.
Based on Oppenheimer & Co's 13F filing for Q3 2024, filed 5 Nov 2024.